Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 8/20 | 0.48 |
| ▸ | METAP2 | P50579 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cambendazole SCHEMBL29409263 | 1.00 | METAP1 (0.48) | METAP1METAP2KDM4ENPC1RAB9A | |
| Cambendazole SCHEMBL8734398 | 0.95 | METAP1 (0.57) | METAP1METAP2KDM4ENPC1RAB9A | |
| Cambendazole SCHEMBL2895694 | 0.92 | METAP1 (0.55) | METAP1METAP2KDM4ENPC1RAB9A | |
| SCHEMBL3500748 | 0.89 | METAP1 (0.52) | METAP1METAP2KDM4ENPC1RAB9A | |
| Mebendazole SCHEMBL2406875 | 0.85 | METAP1 (0.54) | METAP1METAP2KDM4ENPC1RAB9A | |
| Diethenofencarb SCHEMBL9055860 | 0.84 | HPSE (0.51) | METAP1METAP2KDM4ENPC1RAB9A | |
| SCHEMBL11208569 | 0.83 | METAP1 (0.55) | METAP1METAP2KDM4ENPC1RAB9A | |
| SCHEMBL5190850 | 0.82 | TUBB4A (0.43) | KDM4ENPC1RAB9ASMN1; SMN2TP53 | |
| SCHEMBL4367982 | 0.81 | METAP1 (0.50) | METAP1METAP2KDM4ENPC1RAB9A | |
| SCHEMBL4366074 | 0.81 | METAP1 (0.50) | METAP1METAP2KDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4246 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496374-B2 | Deodorizer composition, absorbing body, and absorbent article | SUMITOMO SEIKA CHEMICALS CO, LTD. (JP) | 2025-12-16 | — | — | US | claimed |
| US-20250333775-A1 | DIAGNOSTIC TEST AND THERAPY FOR PATIENTS WITH AUTO-BREWERY SYNDROME | UNIV CALIFORNIA (US) | 2025-10-30 | — | — | US | claimed |
| EP-4586826-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | In the Bowl Animal Health, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2024059837-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | IN THE BOWL ANIMAL HEALTH, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| US-20240066035-A1 | Methods for Enhancing Cytotoxic Cancer Therapy Through Inhibition of ATG4B | NORTHWESTERN UNIVERSITY | 2024-02-29 | — | — | US | claimed |
| WO-2024023353-A1 | COMBINATION OF BUMETANIDE AND A MICROTUBULE INHIBITOR FOR USE IN THE TREATMENT OF CANCER | B&A ONCOMEDICAL (FR) | 2024-02-01 | — | — | WO | claimed |
| US-20240033238-A1 | COMBINATION OF COMPOUNDS FOR USE IN THERAPY | B&A ONCOMEDICAL (FR) | 2024-02-01 | — | — | US | claimed |
| EP-4311548-A1 | COMBINATION OF A NKCC1 PROTEIN INHIBITOR AND A MICROTUBULE INHIBITOR FOR USE IN THE TREATMENT OF CANCER | B & A Therapeutics (FR) | 2024-01-31 | — | — | EP | claimed |
| US-20230381173-A1 | METHODS AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES | TONGLI BIOMEDICAL CO., LTD. (CN) | 2023-11-30 | — | — | US | claimed |
| US-11793816-B2 | Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B | NORTHWESTERN UNIVERSITY (US) | 2023-10-24 | — | — | US | claimed |
| EP-0090368-B1 | ANTHELMINTIC PREPARATIONS | HOECHST UK LIMITED (GB) | 1987-09-02 | — | — | EP | claimed |
| EP-0224249-A1 | Amorphous benzimidazole derivatives | SYNTEX (U.S.A.) INC. (US) | 1987-06-03 | — | — | EP | claimed |
| EP-0202568-A1 | Anthelmintic compositions | SYNTEX (U.S.A.) INC. (US) | 1986-11-26 | — | — | EP | claimed |
| EP-0146573-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTHELMINTIC ACTIVITY, DOSAGE UNITS THEREOF AND METHOD FOR TREATING HELMINTHIASIS IN ANIMALS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-07-03 | — | — | EP | claimed |
| WO-1984004677-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTHELMINTIC ACTIVITY, DOSAGE UNITS THEREOF AND METHOD FOR TREATING HELMINTHIASIS IN ANIMALS | HOECHST AG (DE) | 1984-12-06 | — | — | WO | claimed |
| EP-0059074-B1 | ANTHELMINTIC COMPOSITION AND THE USE THEREOF | SANKYO COMPANY LIMITED (JP) | 1984-10-10 | — | — | EP | claimed |
| US-4468390-A | Anthelmintic composition and the use thereof | SANKYO COMPANY, LIMITED (JP) | 1984-08-28 | — | — | US | claimed |
| EP-0090368-A1 | Anthelmintic preparations | HOECHST UK LIMITED (GB) | 1983-10-05 | — | — | EP | claimed |
| EP-0059074-A1 | Anthelmintic composition and the use thereof | SANKYO COMPANY LIMITED (JP) | 1982-09-01 | — | — | EP | claimed |
| US-4009266-A | METHOD OF TREATMENT OF NEMATODE PARASITE INFECTIONS IN DOMESTIC ANIMALS | AYALEW LIYEW | 1977-02-22 | — | — | US | claimed |